Belararox Ltd.

As of June 30, 2024, Belararox Ltd. carries a market capitalization of 21.73M, placing it among publicly traded companies globally. Its enterprise value stands at 20.10M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2024, Belararox Ltd. has 85.23M shares outstanding.

These figures are as of June 30, 2024.

As of June 30, 2024, Belararox Ltd. maintains a current ratio of 1.46, meaning it holds 1.5x the short-term assets needed to cover near-term liabilities.

Over the twelve months ended June 30, 2024, Belararox Ltd. posted a negative return on equity (ROE) of -29.01, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -22.09, reflecting losses generated across the asset base.

As of the close on July 16, 2026, Belararox Ltd.'s stock has declined approximately 45.31% over the past 52 weeks. The 50-day moving average sits at 0.04, while the 200-day moving average is 0.08.

These figures cover the twelve months ended June 30, 2024. EBITDA reached -3.27M, while operating income came in at -3.28M.

These figures are as of June 30, 2024. Total book value stands at 13.21M, with working capital of 695,721.00 providing operational flexibility.

These figures cover the twelve months ended June 30, 2024. Total shareholder yield is negative at -17.21, meaning Belararox Ltd. raised more capital through share issuance and new debt than it returned via dividends and buybacks.